Qiming Venture Partners USA

Rounds

• T Tenpoint TherapeuticsDevelops YUVEZZI, an FDA-approved eye drop treating presbyopia $85MSeries B · 28 Jan
• R Renasant BioDevelops oral small-molecule drugs for autosomal dominant polycystic kidney disease (ADPKD). $54.5MSeed · 10 Jul

No round matches these filters.

Often invests with

• 5AM Ventures1
• AdBio1
• Atlas Venture1
• British Business Bank1
• Eight Roads1
• EQT Life Sciences1
• EQT Nexus1
• F-Prime1